News
In questa sezione è riportato l’archivio completo delle notizie sulle ATMP, suddivise per area di interesse
- Tutte
- Altro
- Business
- Clinica
- Pricing
CAR T-CELL THERAPIES PREDICTED TO COST MORE THAN $1 MILLION PER PATIENT
Date: Nov 02, 2017 Source: “https://www.ashclinicalnews.org”...
NICE APPROVES NOVEL GSK GENE THERAPY
“https://www.nice.org.uk”...
FDA APPROVES SECOND GENE-ALTERING TREATMENT FOR CANCER
“https://www.nytimes.com/”...
WE MAY SOON HAVE OUR FIRST $1 MILLION DRUG. WHO WILL PAY FOR IT? AND HOW?
Date: Oct 13, 2017 Source: “https://www.statnews.com”...
FDA PANEL UNANIMOUSLY VOTES TO APPROVE GENE THERAPY FOR BLINDNESS
“https://http://edition.cnn.com/”...
CAR-T: NEW FRONTIERS OF MEDICINE BETWEEN INNOVATION AND SUSTAINABILITY
“http://www.agenziafarmaco.gov.it”...
NOVARTIS OBTAINS FDA APPROVAL OF THE FIRST CAR-T THERAPY
“https://www.fda.gov”...
GILEAD ACQUIRES KITE PHARMA
“http://www.gilead.com”...
SPARK THERAPEUTICS SUBMITS MARKETING AUTHORIZATION APPLICATION TO EUROPEAN MEDICINES AGENCY FOR INVESTIGATIONAL LUXTURNA™ (VORETIGENE NEPARVOVEC)
“http://ir.sparktx.com”...
CHIESI ANNOUNCES GLYBERA WITHDRAWAL
“http://www.chiesigroup.com”...
GSK OBTAINS EMA APPROVAL FOR THE FIRST GENE THERAPY
“http://www.ema.europa.eu”...
GENE THERAPY RESTORES SENSE OF SMELL IN MICE
“https://www.nih.gov”...
In Evidenza
DOCUMENTI
12.10.2023 - Scarica la nuova edizione del report ATMP FORUM
31.03.2021 - Documento ATMP per PNRR
22.02.2022 - Le terapie CAR-T in Italia: sfide ed evoluzione del contesto organizzativo
EVENTI
Nessun risultato
La pagina richiesta non è stata trovata. Affina la tua ricerca, o utilizza la barra di navigazione qui sopra per trovare il post.
INTERVISTE
Scopri gli ultimi video Approfondimenti ATMP Forum e le interviste ai Relatori degli ultimi eventi